IL154150A0 - Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts - Google Patents

Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts

Info

Publication number
IL154150A0
IL154150A0 IL15415001A IL15415001A IL154150A0 IL 154150 A0 IL154150 A0 IL 154150A0 IL 15415001 A IL15415001 A IL 15415001A IL 15415001 A IL15415001 A IL 15415001A IL 154150 A0 IL154150 A0 IL 154150A0
Authority
IL
Israel
Prior art keywords
peptide salts
pharmaceutical preparations
preparations containing
producing
salts
Prior art date
Application number
IL15415001A
Other languages
English (en)
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27805895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL154150(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of IL154150A0 publication Critical patent/IL154150A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL15415001A 2000-08-17 2001-08-09 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts IL154150A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040700A DE10040700A1 (de) 2000-08-17 2000-08-17 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
PCT/EP2001/009219 WO2002014347A2 (de) 2000-08-17 2001-08-09 Verfahren zur herstellung von peptidsalzen, deren verwendung und die peptidsalze enthaltende pharmazeutische zubereitungen
CA002355573A CA2355573A1 (en) 2000-08-17 2001-08-22 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts

Publications (1)

Publication Number Publication Date
IL154150A0 true IL154150A0 (en) 2003-07-31

Family

ID=27805895

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15415001A IL154150A0 (en) 2000-08-17 2001-08-09 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts

Country Status (30)

Country Link
US (1) US6780972B2 (xx)
EP (1) EP1309607B1 (xx)
JP (1) JP2004506647A (xx)
CN (1) CN1187369C (xx)
AR (1) AR030371A1 (xx)
AT (1) ATE280779T1 (xx)
AU (2) AU2002210439B2 (xx)
BG (1) BG107612A (xx)
BR (1) BR0113296A (xx)
CA (1) CA2355573A1 (xx)
CZ (1) CZ2003688A3 (xx)
DE (2) DE10040700A1 (xx)
DK (1) DK1309607T3 (xx)
EE (1) EE200300065A (xx)
ES (1) ES2230371T3 (xx)
HK (1) HK1058366A1 (xx)
HU (1) HUP0300738A3 (xx)
IL (1) IL154150A0 (xx)
MX (1) MXPA03001448A (xx)
NO (1) NO20030618L (xx)
NZ (1) NZ524023A (xx)
PL (1) PL204496B1 (xx)
PT (1) PT1309607E (xx)
RU (1) RU2266296C2 (xx)
SI (1) SI1309607T1 (xx)
SK (1) SK3032003A3 (xx)
TW (1) TWI236910B (xx)
UA (1) UA74005C2 (xx)
WO (1) WO2002014347A2 (xx)
ZA (1) ZA200300777B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
RU2525661C2 (ru) * 2012-11-15 2014-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) Способ получения высокотитражной антимикробной сыворотки для оценки антигенной активности противостафилококковых вакцин
CN107056894B (zh) * 2017-05-26 2021-07-20 济南康和医药科技有限公司 一种片段法固相合成醋酸加尼瑞克的方法
EP3590526A1 (en) * 2018-07-05 2020-01-08 Antev Limited A lyophilization process and a teverelix-tfa lyophilizate obtained thereby
CN114249800B (zh) * 2020-09-22 2024-07-26 深圳市星银医药有限公司 一种双羟萘酸多肽药物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
ATE8988T1 (de) * 1980-06-02 1984-09-15 Andrew Victor Schally Lh-rh antagonisten.
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
EP0626170A3 (en) * 1993-05-10 1996-03-27 Sandoz Ltd Stabilization of pharmacoligically active compounds in controlled release compositions.
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
NZ505651A (en) * 1998-01-16 2003-08-29 Takeda Chemical Industries Ltd Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer

Also Published As

Publication number Publication date
WO2002014347A3 (de) 2002-08-08
ES2230371T3 (es) 2005-05-01
US6780972B2 (en) 2004-08-24
NO20030618D0 (no) 2003-02-07
NZ524023A (en) 2004-11-26
ZA200300777B (en) 2003-09-18
US20020198146A1 (en) 2002-12-26
PL204496B1 (pl) 2010-01-29
CN1187369C (zh) 2005-02-02
DE50104316D1 (de) 2004-12-02
PT1309607E (pt) 2005-02-28
BR0113296A (pt) 2003-07-15
AR030371A1 (es) 2003-08-20
NO20030618L (no) 2003-02-07
ATE280779T1 (de) 2004-11-15
RU2003107560A (ru) 2005-01-27
SI1309607T1 (en) 2005-02-28
RU2266296C2 (ru) 2005-12-20
JP2004506647A (ja) 2004-03-04
CN1447817A (zh) 2003-10-08
BG107612A (bg) 2003-12-31
HK1058366A1 (en) 2004-05-14
HUP0300738A3 (en) 2004-08-30
CZ2003688A3 (cs) 2004-03-17
MXPA03001448A (es) 2004-12-13
DK1309607T3 (da) 2005-01-17
HUP0300738A2 (hu) 2003-09-29
EP1309607B1 (de) 2004-10-27
TWI236910B (en) 2005-08-01
SK3032003A3 (en) 2004-05-04
CA2355573A1 (en) 2003-02-22
UA74005C2 (en) 2005-10-17
DE10040700A1 (de) 2002-02-28
AU1043902A (en) 2002-02-25
AU2002210439B2 (en) 2005-10-20
EP1309607A2 (de) 2003-05-14
PL359495A1 (en) 2004-08-23
EE200300065A (et) 2004-12-15
WO2002014347A2 (de) 2002-02-21

Similar Documents

Publication Publication Date Title
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
HUP0302114A3 (en) Liquis pharmaceutical composition comprising erythropoietin protein, method for its preparation and its use
PL349863A1 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
HUP0300209A3 (en) Lipid nanocapsules, preparation method and use as medicine
HRP20010115B1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HUP0302050A3 (en) Pharmaceutical form of administration for peptides, method for its production and use
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
HK1036402A1 (en) Morphine sulphate microgranules, method for makingsame and pharmaceutical preparations.
ZA991482B (en) Lipopeptide antibiotic calcium salts, process for their preparations, and their use.
IL154150A0 (en) Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
AU2002210439A1 (en) Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
HK1042092B (zh) 新的嗎啉衍生物，其製備方法和含有它們的藥物組合物
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU5031801A (en) Memno peptides, a process for their preparation and their use
HUP0200376A2 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.
IL156160A0 (en) Klainetins and their derivatives, method for their preparation and use thereof
IL151216A0 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof
EP1338275A4 (en) Pharmaceutical composition, its use and method of making the same
SI1098874T1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
SI1212313T1 (en) 7-carboxy-flavone derivatives, preparation method and therapeutic use

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees